Veloxis Pharmaceuticals Clinical Trials
Sponsors / Veloxis Pharmaceuticals
Veloxis Pharmaceuticals appears as lead sponsor on 14 trial records in ClinicalTrials.gov. The portfolio currently includes 0 recruiting studies, 0 active non-recruiting studies, and 9 completed studies. 3 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Cumulative planned enrollment across all listed trials is 1,414 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
14
Total Trials
0
Recruiting
0
Other Active
9
Completed
3
Terminated / Withdrawn
1,414
Total Enrollment
Termination reasons: Recruitment67% · Business33%
Recent Terminations
- Chemotherapy-induced Peripheral Neuropathy"Business Decision"
- Kidney Transplant; Complications"poor recruitment during pandemic and after"
- Autoimmune Hepatitis"Study was discontinued due to slow enrollment"